2022
DOI: 10.1016/j.gie.2022.05.008
|View full text |Cite
|
Sign up to set email alerts
|

EUS-directed transgastric interventions in Roux-en-Y gastric bypass anatomy: a multicenter experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
29
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 27 publications
(30 citation statements)
references
References 29 publications
0
29
1
Order By: Relevance
“…Although less frequently encountered, non-PB procedures are equally challenging in patients with SAA. EUS-directed trans-gastric intervention (EDGI) is a collective term used to describe these non-ERCP procedures in patients with SAA which entails access the excluded stomach or the jejunal limb via the creation of de-novo anastomoses using LAMS to perform a wide range of therapeutic and diagnostic procedures [34,35,36 ▪ ].…”
Section: Non-pancreatobiliary Interventionsmentioning
confidence: 99%
“…Although less frequently encountered, non-PB procedures are equally challenging in patients with SAA. EUS-directed trans-gastric intervention (EDGI) is a collective term used to describe these non-ERCP procedures in patients with SAA which entails access the excluded stomach or the jejunal limb via the creation of de-novo anastomoses using LAMS to perform a wide range of therapeutic and diagnostic procedures [34,35,36 ▪ ].…”
Section: Non-pancreatobiliary Interventionsmentioning
confidence: 99%
“…This technique is more focused on applying in patients who receive endoscopic retrograde cholangiopancreatography (ERCP) treatments with post-surgery anatomical changes like Roux-en-Y gastric bypass. Technical success rates can achieve 96% and persistent fistulas may occur in 11.7% patients, but endoscopic closure seems to be effective ( 36 ).…”
Section: Indications and Outcomes Of Ec-lamsmentioning
confidence: 99%
“…In a more recent case-control study, Ghandour and colleagues matched 25 patients with a persistent GG fistula with 50 patients with no evidence of a fistula. Similarly, no patient or procedural characteristics were predictive of fistula persistence except for LAMS dwell time (127 days in cases vs. 48 days in controls, P = 0.02), with incidence of a persistent GG fistula increasing by 9.5 % for every 7 days the LAMS was left in situ [1]. Patients with persistent GG fistulas gained significantly more weight than those without (> 5 % total body weight gain; 33.3 % v. 10.3 %, P = 0.03).…”
mentioning
confidence: 93%
“…Endoscopic ultrasound-directed transgastric ERCP (EDGE), in comparison, is a completely endoscopic procedure that uses a lumen-apposing metal stent (LAMS) to create a gastrogastric (GG) or jejunogastric fistula, bridging the gastric pouch with the excluded stomach and, thus, allowing for more conventional ERCP. Since its first description in 2015, published data on EDGE have demonstrated excellent technical and clinical success rates (91-100 %) [1][2][3]; however, data on long-term outcomes, in particular regarding the incidence and metabolic consequences of persistent GG fistulas, have been limited.…”
mentioning
confidence: 99%